In this study we investigated the variations in SPARC production by peripheral blood cells from chronic myeloid leukemia (CML) patients at diagnosis and after treatment and we identified the subpopulation of cells that are the prevalent source of SPARC. The gene discussed is SPARC; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.